Press releases
- MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference
- Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement
- MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder
- MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120
- MindMed Reports 2023 Financial Results and Business Updates
- MindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business Update
- MindMed to Participate in the 34th Annual Oppenheimer Healthcare Life Sciences Conference
- MindMed Announces Business Update and Anticipated Milestones for 2024
More ▼
Key statistics
As of last trade Mind Medicine (MindMed) Inc (MMQ:DUS) traded at 8.72, -10.29% below its 52-week high of 9.72, set on Mar 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.68 |
---|---|
High | 8.72 |
Low | 8.68 |
Bid | 8.95 |
Offer | 9.16 |
Previous close | 8.91 |
Average volume | 2.02k |
---|---|
Shares outstanding | 70.27m |
Free float | 68.55m |
P/E (TTM) | -- |
Market cap | 667.55m USD |
EPS (TTM) | -2.45 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 11:31 BST.
More ▼